In House Pipeline
Leveraging our proprietary technology for composite programmable therapeutics, we have developed an in-house pipeline of treatment solutions for infectious diseases and delivery of genetic medicines.
Development Pipeline
- Discovery
- Preclinical Validation
- Lead Optimization
- IND-Enabling
- Phase I
- Phase II/III
Infectious Diseases
Infectious Diseases
A cutting-edge non-viral vector gene delivery platform designed for in vivo CAR-T generation and broader applications in genetic medicine.
The CPTx pipeline was developed to validate the composite programmable therapeutic technology as a rapid response platform for viral threats.
The viral countermeasures platform - universal and adaptable virus cell entry inhibitor
Prototypes
Viral Countermeasures Platform
- Modularity
Capture different types of viruses, regardless of form and size.
- Compatibility
Compatible with a wide range of virus-binding molecules such as antibodies, peptides, and polymers.
- Adaptability
Robust trapping of viruses, offering resistance against viral mutations.
- Broad-Spectrum Activity
Disable many viruses using the same formulation.
- Viral Load Reduction
Suppresses viral reproduction as a cell entry inhibitor.
- Flexible Administration
Intravenous, subcutaneous or intranasal administration for prevention or treatment of acute infections.
- Chemically Inert
Built from biological material, does not interfere with host metabolism.
- Add on Capacity
The system can carry additional effector functionalities to further support pathogen removal.